ReShape Lifesciences Stock Forecast - Accumulation Distribution
| RSLS Stock | USD 0.18 0.01 5.88% |
ReShape Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast ReShape Lifesciences stock prices and determine the direction of ReShape Lifesciences's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of ReShape Lifesciences' historical fundamentals, such as revenue growth or operating cash flow patterns. Although ReShape Lifesciences' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of ReShape Lifesciences' systematic risk associated with finding meaningful patterns of ReShape Lifesciences fundamentals over time.
Check out Historical Fundamental Analysis of ReShape Lifesciences to cross-verify your projections. ReShape |
Most investors in ReShape Lifesciences cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the ReShape Lifesciences' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets ReShape Lifesciences' price structures and extracts relationships that further increase the generated results' accuracy.
The accumulation distribution (A/D) indicator shows the degree to which ReShape Lifesciences is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of ReShape Lifesciences to determine if accumulation or reduction is taking place in the market. This value is adjusted by ReShape Lifesciences trading volume to give more weight to distributions with higher volume over lower volume.| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 7246.35 | 19220.67 |
| Check ReShape Lifesciences Volatility | Backtest ReShape Lifesciences | Trend Details |
ReShape Lifesciences Trading Date Momentum
| On April 10 2024 ReShape Lifesciences was traded for 0.17 at the closing time. The top price for the day was 0.18 and the lowest listed price was 0.16 . The trading volume for the day was 228.4 K. The trading history from April 10, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare ReShape Lifesciences to competition |
Other Forecasting Options for ReShape Lifesciences
For every potential investor in ReShape, whether a beginner or expert, ReShape Lifesciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ReShape Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ReShape. Basic forecasting techniques help filter out the noise by identifying ReShape Lifesciences' price trends.ReShape Lifesciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ReShape Lifesciences stock to make a market-neutral strategy. Peer analysis of ReShape Lifesciences could also be used in its relative valuation, which is a method of valuing ReShape Lifesciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ReShape Lifesciences Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ReShape Lifesciences' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ReShape Lifesciences' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
ReShape Lifesciences Market Strength Events
Market strength indicators help investors to evaluate how ReShape Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ReShape Lifesciences shares will generate the highest return on investment. By undertsting and applying ReShape Lifesciences stock market strength indicators, traders can identify ReShape Lifesciences entry and exit signals to maximize returns.
ReShape Lifesciences Risk Indicators
The analysis of ReShape Lifesciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ReShape Lifesciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting reshape stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.15 | |||
| Standard Deviation | 4.39 | |||
| Variance | 19.28 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether ReShape Lifesciences is a strong investment it is important to analyze ReShape Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ReShape Lifesciences' future performance. For an informed investment choice regarding ReShape Stock, refer to the following important reports:Check out Historical Fundamental Analysis of ReShape Lifesciences to cross-verify your projections. For more information on how to buy ReShape Stock please use our How to Invest in ReShape Lifesciences guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for ReShape Stock analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is ReShape Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReShape Lifesciences. If investors know ReShape will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReShape Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Revenue Per Share 1.457 | Quarterly Revenue Growth (0.36) | Return On Assets (0.84) | Return On Equity (2.21) |
The market value of ReShape Lifesciences is measured differently than its book value, which is the value of ReShape that is recorded on the company's balance sheet. Investors also form their own opinion of ReShape Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is ReShape Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReShape Lifesciences' market value can be influenced by many factors that don't directly affect ReShape Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReShape Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ReShape Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReShape Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.